| UPSA Switzerland AG - Dafalgan 500 mg, Tabletten | | 46206 | | 01 | | Dafalgan 500 mg | | Tabletten | | N02BE01 | | Paracetamol | | 17.05.1985 | | |
| | Composition | | paracetamolum 500 mg, acidum stearicum, carboxymethylamylum natricum A, talcum, povidonum K 30, maydis amylum, silica colloidalis hydrica, pro compresso corresp. natrium 1.05 mg. | | Packungsbestandteile | | Comprimés | | | | | Principe actif | Concentr. |
|---|
| Paracetamole | 500 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Paracetamole | 500 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Stearicum | | | Carboxymethylamylum Natricum A | | | Maydis Amylum | | | Povidonum K | 30 | | Pro Compresso | | | Silica Colloidalis Hydrica | | | Talcum | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 007 | 30 | 2.19 | 6.60 | B | LS | Non | | 008 | 100 | 5.95 | 15.05 | B | LS | Non |
|
|
